Specifically, the first application is devoted to study the association between a single nucleotide polymorphism (SNP) and CRC in carriers of a pathogenic variant in the PMS2 gene while the second one focuses on the association of a 161 SNP‐based PRS with breast cancer. This evidence concerns the gene PMS2 and breast carcinoma.